tiprankstipranks
Trending News
More News >

Shandong Xinhua Pharmaceutical Secures Drug Registration for Memantine Solution

Story Highlights
Shandong Xinhua Pharmaceutical Secures Drug Registration for Memantine Solution

Don’t Miss TipRanks’ Half-Year Sale

Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has provided an announcement.

Shandong Xinhua Pharmaceutical Company Limited has announced the receipt of the Drug Registration Certificate for its Memantine hydrochloride oral solution from the National Medical Products Administration. This approval marks a significant milestone for the company, enabling it to proceed with the production and sale of the drug, potentially enhancing its market position in the pharmaceutical industry.

More about Shandong Xinhua Pharmaceutical Company Limited Class H

Shandong Xinhua Pharmaceutical Company Limited is a pharmaceutical company based in China, specializing in the production of chemical drugs. The company focuses on the development and manufacturing of prescription medications, contributing to the healthcare industry with a range of pharmaceutical products.

YTD Price Performance: -6.37%

Average Trading Volume: 2,139,988

Technical Sentiment Signal: Hold

Current Market Cap: HK$8.49B

Find detailed analytics on 0719 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1